While Core Laboratories Inc has overperformed by 3.72%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CLB fell by -31.34%, with highs and lows ranging from $25.13 to $10.14, whereas the simple moving average fell by -35.02% in the last 200 days.
On March 12, 2025, Citigroup Upgraded Core Laboratories Inc (NYSE: CLB) to Neutral. A report published by Citigroup on June 30, 2023, Downgraded its rating to ‘Sell’ for CLB. BofA Securities also Downgraded CLB shares as ‘Underperform’, setting a target price of $21.50 on the company’s shares in a report dated April 18, 2023. Citigroup October 07, 2022d its ‘Sell’ rating to ‘Neutral’ for CLB, as published in its report on October 07, 2022. Morgan Stanley’s report from September 26, 2022 suggests a price prediction of $20 for CLB shares, giving the stock a ‘Underweight’ rating. Piper Sandler also rated the stock as ‘Underweight’.
Analysis of Core Laboratories Inc (CLB)
CLB currently pays a dividend of $0.04 per share, which means investors will get a return regardless of the company’s performance over the next few months. Further, the quarter-over-quarter decrease in sales is -4.67%, showing a negative trend in the upcoming months.
In order to gain a clear picture of Core Laboratories Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 11.54% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.64, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 457.12K can be a very valuable indicator of volatility for CLB stock. On a monthly basis, the volatility of the stock is set at 8.34%, whereas on a weekly basis, it is put at 8.98%, with a loss of -5.79% over the past seven days. Furthermore, long-term investors anticipate a median target price of $15.40, showing growth from the present price of $11.72, which can serve as yet another indication of whether CLB is worth investing in or should be passed over.
How Do You Analyze Core Laboratories Inc Shares?
The USA based company Core Laboratories Inc (CLB) is one of the biggest names in Oil & Gas Equipment & Services. When comparing Core Laboratories Inc shares with other companies under Energy, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 19.98, there is a growth in quarterly earnings of -104.89%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.13%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 109.07% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CLB shares are owned by institutional investors to the tune of 109.07% at present.
